Connect with us

Technology

Next-Generation Sequencing Services Market Poised for Remarkable Growth: Projected to Increase from $7 Billion in 2024 to $15 Billion by 2031: – Market Research Intellect

Published

1 year ago

on

The Next-Generation Sequencing (NGS) Services Market is driven by several key factors, including significant advancements in sequencing technologies that enhance accuracy and speed. The declining costs of sequencing are making it more accessible to researchers and healthcare providers. Additionally, the rising prevalence of genetic disorders and the growing emphasis on personalized medicine are fueling demand for NGS services.

LEWES, Del., Jan. 23, 2025 /PRNewswire/ — The Next-Generation Sequencing (NGS) Services Market is projected to grow from approximately USD 7 billion in 2024 to around USD 15 billion by 2031, achieving a compound annual growth rate (CAGR) of about 11%. This growth is fueled by advancements in sequencing technologies, reduced costs, and an increasing emphasis on personalized medicine and genetic research applications.

Download PDF Brochure: https://www.marketresearchintellect.com/download-sample/?rid=1018094

202 – Pages
126 – Tables
37 – Figures

Scope Of The Report

REPORT ATTRIBUTES

DETAILS

STUDY PERIOD

2020-2031

BASE YEAR

2023

FORECAST PERIOD

2024-2031

HISTORICAL PERIOD

2020-2023

UNIT

Value (USD Billion)

KEY COMPANIES PROFILED

Illumina, Inc., Thermo Fisher Scientific Inc., Pacific Biosciences of California, Inc., Roche Diagnostics, BGI Genomics Co., Ltd., Agilent Technologies, Inc., QIAGEN N.V., PerkinElmer, Inc., Bio-Rad Laboratories, Inc., and Oxford Nanopore Technologies Ltd.

SEGMENTS COVERED

By Type, By Application And By Geography

CUSTOMIZATION SCOPE

Free report customization (equivalent to up to 4 analysts’ working days) with purchase. Addition or alteration to country, regional & segment scope

Next-Generation Sequencing (NGS) Services Market Overview

Market Growth and Size

The Next-Generation Sequencing (NGS) Services Market is on a robust growth trajectory, expected to expand from approximately USD 7 billion in 2024 to around USD 15 billion by 2031. This impressive growth reflects a compound annual growth rate (CAGR) of about 11%. Several factors contribute to this upward trend, including the increasing demand for genomic analysis across various sectors, such as healthcare, agriculture, and personalized medicine. As more research institutions and healthcare providers adopt NGS technologies, the market is likely to witness heightened investment in innovative sequencing solutions. Furthermore, the rising incidence of genetic disorders and the need for accurate diagnostic tools will continue to stimulate market expansion. This growth presents significant opportunities for key players and stakeholders in the NGS industry to enhance their service offerings and meet the evolving needs of end-users.

Technological Advancements

Technological advancements play a pivotal role in shaping the Next-Generation Sequencing Services Market. Innovations in sequencing technologies, such as improved algorithms and automated systems, have significantly enhanced the speed and accuracy of genomic analysis. Companies are increasingly developing high-throughput sequencing platforms that allow for the rapid processing of large volumes of genetic data. Additionally, advancements in bioinformatics tools enable more efficient data analysis and interpretation, making it easier for researchers to derive meaningful insights from genomic information. These technological breakthroughs are not only reducing the costs associated with sequencing but also expanding its applications in various fields, including oncology, reproductive health, and infectious diseases. As technology continues to evolve, it will likely pave the way for new services and applications within the NGS market, driving further growth and innovation.

Rising Demand for Personalized Medicine

The growing emphasis on personalized medicine is a significant driver of the Next-Generation Sequencing Services Market. As healthcare shifts towards more individualized treatment approaches, the need for precise genomic information becomes paramount. NGS technologies enable the identification of genetic variations that can influence drug efficacy and patient response, leading to tailored treatment plans that enhance patient outcomes. The application of NGS in oncology, for example, allows for the profiling of tumors to identify specific mutations, guiding targeted therapy decisions. Additionally, advancements in pharmacogenomics, which studies how genes affect a person’s response to drugs, further fuel demand for NGS services. As healthcare providers increasingly recognize the value of personalized medicine, the NGS market is expected to expand significantly, with more providers integrating these services into their practice to deliver optimized patient care.

Application in Clinical Diagnostics

Next-Generation Sequencing is becoming an integral component of clinical diagnostics, transforming the way genetic disorders are diagnosed and managed. The ability to sequence entire genomes or targeted gene panels allows for the identification of genetic mutations associated with various diseases. This capability enhances diagnostic accuracy and provides critical information for patient management and treatment decisions. For instance, NGS is widely used in prenatal testing, cancer diagnostics, and rare disease identification, enabling early intervention and improved outcomes. As regulatory bodies increasingly approve NGS-based diagnostic tests, healthcare providers are more likely to adopt these technologies, driving market growth. The integration of NGS into clinical workflows also facilitates the development of companion diagnostics, which further enhances the personalization of treatment strategies. This trend underscores the importance of NGS in modern healthcare and its potential to revolutionize clinical diagnostics.

Download Sample Report Now: https://www.marketresearchintellect.com/download-sample/?rid=1018094

Increasing Research Initiatives

The Next-Generation Sequencing Services Market is also benefitting from a surge in research initiatives across academia and industry. Governments, research institutions, and private organizations are investing significantly in genomics research to explore the genetic basis of diseases, improve agricultural practices, and advance biotechnology. This influx of funding is facilitating the establishment of large-scale genomic projects and biobanks that utilize NGS technologies to generate vast datasets for analysis. Collaborative efforts among researchers, institutions, and industry stakeholders are also driving innovation and expanding the applications of NGS in various fields, including environmental science and conservation. As research initiatives continue to grow, they will contribute to the advancement of NGS technologies and methodologies, ensuring a steady demand for sequencing services. This dynamic environment fosters a culture of discovery and innovation, positioning NGS as a cornerstone of modern scientific inquiry.

Challenges and Limitations

Despite its significant growth prospects, the Next-Generation Sequencing Services Market faces several challenges and limitations. One major concern is the complexity of data generated by NGS technologies, which can lead to data management and analysis difficulties. The sheer volume of genomic data requires sophisticated bioinformatics tools and skilled personnel to interpret the results accurately. Additionally, the high initial costs associated with implementing NGS platforms may pose a barrier for smaller laboratories and healthcare facilities. Regulatory challenges also exist, particularly in ensuring the quality and reliability of NGS-based diagnostic tests. Moreover, ethical considerations surrounding genetic data privacy and consent remain critical issues that the industry must address. Overcoming these challenges will be essential for the continued growth and adoption of NGS services, necessitating collaboration among industry stakeholders to develop standardized practices and solutions.

Competitive Landscape

The competitive landscape of the Next-Generation Sequencing Services Market is characterized by a diverse range of players, including established companies and emerging startups. Major industry leaders are continually innovating and expanding their service portfolios to maintain a competitive edge. Strategic collaborations, partnerships, and acquisitions are common as companies seek to enhance their technological capabilities and market reach. Additionally, the entry of new players with specialized NGS services is intensifying competition, driving further advancements in technology and service offerings. As the market evolves, companies are focusing on providing integrated solutions that encompass sequencing, bioinformatics, and data analysis, catering to the diverse needs of researchers and clinicians. This dynamic competitive environment encourages continuous improvement and innovation, ultimately benefiting end-users and advancing the field of genomics.

Future Outlook

The future outlook for the Next-Generation Sequencing Services Market is exceptionally promising, with sustained growth anticipated through 2031 and beyond. As genomic technologies continue to evolve, the scope of NGS applications is expected to expand, encompassing areas such as personalized medicine, precision agriculture, and infectious disease monitoring. The increasing integration of artificial intelligence and machine learning in genomic data analysis will enhance the accuracy and efficiency of NGS services, making them even more valuable to researchers and healthcare providers. Furthermore, ongoing collaborations between public and private sectors will likely accelerate research and development efforts, driving innovation in NGS technologies. As awareness of the importance of genomics in healthcare and research continues to rise, the NGS services market will play a crucial role in shaping the future of medicine and biotechnology, offering vast opportunities for growth and development.

Geographic Dominance:

The Next-Generation Sequencing (NGS) Services Market exhibits significant geographic dominance, particularly in North America and Europe. North America holds a substantial share, driven by advanced healthcare infrastructure, high investments in research and development, and the presence of leading biotechnology and pharmaceutical companies. The U.S. is at the forefront of NGS innovation, with numerous academic institutions and laboratories leveraging these technologies for cutting-edge research. Europe follows closely, with countries like Germany, the UK, and France investing heavily in genomics and personalized medicine initiatives. Additionally, the Asia-Pacific region is emerging as a key player, with increasing adoption of NGS technologies in countries like China and Japan, driven by government support and growing healthcare expenditures. As awareness of genomic applications expands globally, the NGS market is expected to witness significant growth across various regions, fostering a competitive landscape.

Next-Generation Sequencing (NGS) Services Market Key Players Shaping the Future

Key players shaping the future of the Next-Generation Sequencing (NGS) Services Market include Illumina, Inc., Thermo Fisher Scientific Inc., Pacific Biosciences of California, Inc., Roche Diagnostics, BGI Genomics Co., Ltd., Agilent Technologies, Inc., QIAGEN N.V., PerkinElmer, Inc., Bio-Rad Laboratories, Inc., and Oxford Nanopore Technologies Ltd. These companies are at the forefront of innovation, driving advancements in NGS technologies and expanding their service offerings to meet the growing demand for genomic analysis across various applications, from clinical diagnostics to research and development.

Next-Generation Sequencing (NGS) Services Market Segment Analysis

The Next-Generation Sequencing (NGS) Services market is segmented based on By Type, By Application and Geography, offering a comprehensive analysis of the industry.

1. By Type

Whole Genome Sequencing (WGS): This method involves sequencing the entire genome of an organism, providing comprehensive genetic information. WGS is used in various applications, including population genetics, evolutionary biology, and personalized medicine, enabling a thorough understanding of genetic variations and their implications.Targeted Sequencing: Focused on specific areas of interest within the genome, targeted sequencing is more cost-effective and faster than WGS. It is commonly used in clinical diagnostics to identify mutations associated with particular diseases, making it essential for cancer genomics and inherited disorders.Exome Sequencing: This technique sequences only the coding regions of genes, known as exomes. Exome sequencing is widely used in rare disease research and cancer studies, providing valuable insights while reducing the amount of data that needs to be analyzed compared to WGS.RNA Sequencing (RNA-seq): RNA-seq analyzes the transcriptome, offering insights into gene expression and regulation. This method is crucial for understanding diseases at the molecular level, particularly in cancer research and developmental biology, where gene expression patterns play a significant role.Other Sequencing Types: This category may include techniques such as methylation sequencing and amplicon sequencing, which serve specific research purposes. These methods contribute to the understanding of epigenetic modifications and targeted genomic regions, respectively.

2. By Application

Clinical Diagnostics: NGS plays a crucial role in identifying genetic mutations linked to various diseases, including cancers and hereditary disorders. The ability to provide accurate and timely diagnoses enhances patient management and treatment strategies, driving the demand for NGS services in clinical settings.Drug Discovery: In the pharmaceutical industry, NGS is leveraged to identify potential drug targets and understand disease mechanisms at the molecular level. By enabling researchers to analyze genetic variations, NGS accelerates the drug development process and helps in the design of personalized therapies.Biomarker Discovery: NGS is instrumental in discovering and validating biomarkers for disease diagnosis and prognosis. This application is particularly relevant in oncology, where identifying specific genetic alterations can inform treatment decisions and improve patient outcomes.Agriculture: NGS technologies are increasingly used in agricultural research to enhance crop traits and improve food security. By analyzing the genomes of plants and animals, researchers can identify beneficial traits, develop genetically modified organisms, and improve breeding programs.Environmental Testing: NGS is applied in environmental studies to monitor biodiversity and assess ecosystem health. By sequencing microbial communities and assessing their genetic composition, researchers can gain insights into environmental changes and their implications for public health and conservation efforts.

3. Geography

North America: This region dominates the NGS Services Market due to its advanced healthcare infrastructure, high research funding, and the presence of leading biotechnology companies. The U.S. is a key player in NGS innovation, driving significant market growth through technological advancements and widespread adoption of genomic technologies.Europe: Europe follows closely, with countries like Germany, the UK, and France investing heavily in genomics and personalized medicine initiatives. The European market is characterized by collaborations among research institutions, universities, and industry stakeholders, fostering innovation and expanding the use of NGS services.Asia-Pacific: The Asia-Pacific region is emerging as a significant market for NGS services, driven by increasing healthcare expenditures and government support for research initiatives. Countries like China and Japan are at the forefront of adopting NGS technologies, with a focus on genomics research and clinical applications.Latin America: The Latin American NGS market is experiencing growth as awareness of genomic technologies increases among healthcare providers and researchers. Emerging economies in this region are gradually adopting NGS for clinical diagnostics and research, creating opportunities for market expansion.Middle East & Africa: The NGS Services Market in the Middle East and Africa is in its early stages but shows potential for growth. Increasing investments in healthcare infrastructure and research initiatives are expected to drive demand for NGS services in these regions, although challenges such as limited access to advanced technologies persist.

Pharma And Healthcare:

The Pharma and Healthcare segment of the Next-Generation Sequencing (NGS) Services Market is experiencing significant growth, driven by the increasing demand for personalized medicine and advancements in genomics. NGS technologies facilitate the comprehensive analysis of genetic variations, enabling healthcare providers to tailor treatments based on individual patient profiles. This is particularly impactful in oncology, where genomic sequencing can identify mutations that inform targeted therapies. Additionally, NGS plays a critical role in clinical diagnostics, allowing for the early detection of genetic disorders and enhancing disease management strategies. As pharmaceutical companies integrate NGS into drug development processes, the ability to identify novel biomarkers accelerates the discovery of effective therapies. The rising prevalence of chronic diseases and genetic conditions further fuels the adoption of NGS services in healthcare settings. Overall, the Pharma and Healthcare segment is poised for continued expansion, contributing significantly to the overall growth of the NGS Services Market.

Our related Reports

Global Single Use Next-Generation Sequencing (NGS) Services Market is categorized based on Type (420 Stainless Steel, 40Cr13 Stainless Steel, 30Cr13 Stainless Steel, 2Cr13 Stainless Steel, Others) and Application (Hospitals, Ophthalmic Clinics, Others) and geographical regions

Global Classroom Messaging Software market size and forecast is categorized based on Type (Cloud Based, Web Based) and Application (Large Enterprises, SMEs) and geographical regions

Global Silicon carbide sic semiconductor market size forecast is categorized based on Type (SIC Power Semiconductors, SIC Power Semiconductor Devices, SIC Power Diode Nodes) and Application (Automotive, Aerospace and Defense, Computers, Consumer Electronics, Industrial, Healthcare, Power Sector, Solar) and geographical regions

Global Automotive Pneumatic Disc Brake Market is categorized based on Type (Single-piston Pneumatic Disc Brakes, Multi-piston Pneumatic Disc Brakes, Caliper Pneumatic Disc Brakes, Rotor Pneumatic Disc Brakes, Drum-in-hat Pneumatic Disc Brakes) and Application (Passenger Cars, Commercial Vehicles, Racing Cars, Heavy-duty Trucks, Off-road Vehicles) and geographical regions

Global Antibacterial Nano Coatings Market is categorized based on Application (Silver Nanoparticle Coatings, Copper Nanoparticle Coatings, Zinc Oxide Nanoparticle Coatings) and Product (Medical Devices (Implants, Catheters), Food Packaging, Textiles, Healthcare Surfaces) and geographical regions

Global Antibacterial in Agriculture Market is categorized based on Type (Amide Antibacterials, Antibiotic Antibacterials, Copper-Based Antibacterials, Dithiocarbamate Antibacterials, Other Types) and Application (Foliar Spray, Soil Treatment, Other Modes of Application) and geographical regions

About Us: Market Research Intellect

Welcome to Market Research Intellect, where we lead the way in global research and consulting, proudly serving over 5,000 esteemed clients worldwide. Our mission is to empower your business with cutting-edge analytical research solutions, delivering comprehensive, information-rich studies that are pivotal for strategic growth and critical revenue decisions.

Unmatched Expertise: Our formidable team of 250 highly skilled analysts and subject matter experts (SMEs) is the backbone of our operations. With extensive training in advanced data collection and governance, we delve into over 25,000 high-impact and niche markets. Our experts seamlessly integrate modern data collection techniques, robust research methodologies, and collective industry experience to produce precise, insightful, and actionable research.

Diverse Industry Coverage: We cater to a wide array of industries, ensuring that our insights are both relevant and specialized. Our expertise spans: Energy, Technology, Manufacturing and Construction, Chemicals and Materials, Food and Beverages

Having collaborated with numerous Fortune 2000 companies, we bring unparalleled experience and reliability to meet all your research needs. Our proven track record reflects our commitment to excellence and client satisfaction.

Contact Us:
Mr. Edwyne Fernandes
Market Research Intellect
Call Us on: +1 743 222 5439
Email: sales@marketresearchintellect.com
Web: https://www.marketresearchintellect.com/

Logo: https://mma.prnewswire.com/media/2483702/Market_Research_Intellect_Logo.jpg

 

View original content:https://www.prnewswire.co.uk/news-releases/next-generation-sequencing-services-market-poised-for-remarkable-growth-projected-to-increase-from-7-billion-in-2024-to-15-billion-by-2031—market-research-intellect-302358326.html

Related Topics:
Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Technology

Galaxy Digital Inc. Announces Pricing of $3.507 Billion of Senior Secured Notes

Published

33 minutes ago

on

July 24, 2026

By

NEW YORK, July 23, 2026 /PRNewswire/ — Galaxy Digital Inc. (NASDAQ: GLXY) (“Galaxy” or the “Company”), a global leader in digital assets and data center infrastructure, today announced that its indirect wholly owned subsidiary, Galaxy Helios Data Centers II LLC (the “Issuer”), has priced a $3.507 billion private offering (the “Offering”) of 9.875% senior secured notes due 2031 (the “Notes”). The Offering is expected to close on July 28, 2026, subject to market and other conditions.

The Issuer intends to use the net proceeds from the Offering to finance a portion of the development and construction of two buildings containing eight data halls with a combined total of 400 megawatts (“MW”) of utility capacity and 260 MW of critical IT capacity (the “Project”) to be built on an approximately 260-acre property in Dickens County, Texas and to fund debt service reserves.

The Notes will bear interest at a rate of 9.875% per annum payable semi-annually in cash in arrears on February 1 and August 1 of each year, beginning on February 1, 2027 and will mature on August 1, 2031. The Notes will amortize at a rate of 4.00% per annum of the original principal amount subject to adjustment, with amortization payments payable semi-annually with the first payment date to occur at least ten months after the completion of the Project.

The Notes will be fully and unconditionally guaranteed by Galaxy Helios II LLC, a wholly owned direct subsidiary of the Issuer (the “Guarantor”), and will constitute the senior secured obligations of the Issuer and the Guarantor. The Notes and related note guarantee will be secured by first-priority liens on (i) substantially all assets of the Issuer and the Guarantor, other than certain excluded property and (ii) all equity interests of the Issuer held by the direct parent company of the Issuer.

The Offering is subject to market and other conditions, and there can be no assurance as to whether, when or on what terms the Offering may be completed.

The Notes have not been registered under the Securities Act or the securities laws of any other jurisdiction, and the Notes may not be offered or sold in the United States absent registration or an applicable exemption from registration under the Securities Act and any applicable state securities laws. The Notes will be offered only to persons reasonably believed to be qualified institutional buyers under Rule 144A under the Securities Act and outside the United States to non-U.S. persons in reliance on Regulation S under the Securities Act.

This press release shall not constitute an offer to sell, or a solicitation of an offer to buy the Notes, nor shall there be any sale of the Notes in any state or jurisdiction in which such an offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.

About Galaxy

Galaxy Digital Inc. (Nasdaq: GLXY) is a global leader in digital assets and data center infrastructure, delivering solutions that accelerate progress in finance and artificial intelligence. Our digital assets platform offers institutional access to trading, advisory, asset management, staking, self-custody, and tokenization technology. In addition, we develop and operate cutting-edge data center infrastructure to power AI and HPC workloads. Our 1.63 GW Helios campus in Texas positions Galaxy among the largest and fastest-growing data center developers in North America. The Company is headquartered in New York City, with offices across North America, Europe, the Middle East, and Asia.

Forward Looking Statements

This press release includes forward-looking statements, including statements relating to the completion, size and timing of the Offering, the terms of the Notes and the intended use of proceeds. The Company intends such forward-looking statements to be covered by the safe harbor provisions for forward-looking statements contained in the Private Securities Litigation Reform Act of 1995 and includes this statement for purposes of complying with these safe harbor provisions. Forward-looking statements represent the Company’s current expectations regarding future events and are subject to known and unknown risks and uncertainties that could cause actual results to differ materially from those implied by the forward-looking statements. Among those risks and uncertainties are market conditions, including market interest rates, the satisfaction of the closing conditions related to the Offering and risks relating to the Company’s business, including those described in periodic reports that the Company files from time to time with the SEC. The Issuer may not consummate the proposed Offering described in this press release and, if the proposed Offering is consummated, cannot provide any assurances regarding the final terms of the Offering or the Notes or its ability to effectively apply the net proceeds as described above. The forward-looking statements included in this press release speak only as of the date of this press release, and the Company does not undertake to update the statements included in this press release for subsequent developments, whether as a result of new information, future events, or otherwise, except as may be required by law.

View original content to download multimedia:https://www.prnewswire.com/news-releases/galaxy-digital-inc-announces-pricing-of-3-507-billion-of-senior-secured-notes-302833899.html

SOURCE Galaxy Digital Inc.

Continue Reading

Technology

The Finish Line that Changed China: Retracing the Long March to Yan’an

Published

33 minutes ago

on

July 24, 2026

By

BEIJING, July 23, 2026 /PRNewswire/ — A news report from China.org.cn on the Long March, and what it means for China today:

 

Every journey has a destination.

But some destinations become the beginning of something even greater.

This is Yan’an.

Over 90 years ago, an army of soldiers embarked from Yudu, Jiangxi Province, on a journey that would go down in history.

They crossed snow-capped mountains, vast grasslands and raging rivers, eventually arriving in northern Shaanxi.

Across this grueling 12,500-kilometer journey, they wrote a magnificent epic in human history with willpower and courage.

Here, their Long March came to a victorious end. But a new chapter of history was only beginning.

In Yan’an, the Red Army found time to recover and rebuild, and the Central Committee of the Communist Party of China regrouped, gathering strength for the next chapter.

Here, new ideas were debated, new strategies were shaped, and a vision for China’s future gradually took form.

Today, while preserving its revolutionary legacy, Yan’an has grown into a vibrant, modern city — with a greener environment, thriving industries and happier lives for its people.

Nearly 90 years ago, American journalist Edgar Snow came to northern Shaanxi, seeking to uncover a story that few outside China knew. He later chronicled it in his book “Red Star Over China,” which carried the story of the Long March to the world.

Today, people from around the world are once again retracing those steps.

As part of China International Communications Group (CICG)’s “Together on the Long March” international communication project, participants have spent more than a month retracing the route across six key regions.

From Jiangxi to Shaanxi, they followed the Red Army’s journey and witnessed the remarkable changes that have taken place along the way.

I asked them one simple question: What does this journey mean to you?

Zhavier Harris, marketing and communications manager at the Springfield Urban League, said conversations with local residents and descendants of the Red Army made history feel far more immediate than he had expected.

He said history isn’t as distant as we often think. “We’re only one or two generations from these great sacrifices that led to the development and the greatness that we see from the Communist Party of China and China as a whole.”

David Ferguson, honorary chief English editor at Foreign Languages Press under CICG and a recipient of the 2021 Chinese Government Friendship Award, said the journey deepened his understanding of the Long March.

He said the journey helped him understand not only the historical facts, but also what the Red Army endured. “If you see the Long March merely as a military campaign, it ended in Yan’an. But as a spirit, it has never truly come to an end.”

We came to retrace history. We leave with something more: a deeper understanding of China’s past, a clearer view of its present, and perhaps a greater appreciation for the stories that connect us across cultures.

Edgar Snow called the Long March “an Odyssey unequalled in modern times.” He believed that what sustained it was a flame — consisting of an undimmed ardor, an undying hope and an amazing revolutionary optimism.

Ninety years later, that flame still burns.

Passed down through generations, the spirit of the Long March continues to light China’s path forward.

And as it crosses borders and cultures, it offers the world a glimpse of a nation defined by resilience, perseverance and an enduring drive to move forward.

China Mosaic
http://www.china.org.cn/video/node_7230027.htm 

The Finish Line that Changed China: Retracing the Long March to Yan’an
http://www.china.org.cn/video/2026-07/23/content_118614941.shtml

View original content to download multimedia:https://www.prnewswire.com/news-releases/the-finish-line-that-changed-china-retracing-the-long-march-to-yanan-302833900.html

SOURCE China.org.cn

Continue Reading

Technology

Visa and Lianlian Advance Trusted B2B Agentic Commerce Through LoopXPay’s First Live B2B Agentic Transaction

Published

33 minutes ago

on

July 24, 2026

By

First live B2B agentic transaction in Greater China highlights how AI-enabled commerce can help SMBs streamline purchasing and payments, supported by Visa’s Agentic Directory for trusted AI agent interactions

SINGAPORE, July 24, 2026 /PRNewswire/ — Visa (NYSE: V), a global leader in digital payments, and Lianlian DigiTech Co., Ltd. (“Lianlian”), an AI-native global financial infrastructure provider, today announced the first live B2B agentic transaction completed using LoopXPay, Lianlian’s AI agent. 

Small and medium sized businesses (SMBs) often lack dedicated procurement teams and spend valuable time sourcing, purchasing and making payments themselves. In the transaction, the LoopXPay agent was used to source a product sample from a supplier and complete the purchase in a single workflow. The agent identified the purchasing requirement, recommended suitable suppliers, compared options, placed the order and securely executed the payment within a single workflow, while operating within pre-defined spending controls and approval parameters.

The milestone highlights how AI-powered commerce experiences can help SMBs simplify purchasing and payment activities while maintaining appropriate controls and oversight. By enabling AI agents to operate within pre-defined spending parameters and approval controls, businesses can reduce manual effort while retaining visibility into commercial decision-making.

As AI agents become more involved in purchasing and payment activities, businesses will require confidence that transactions are being executed by verified participants, within approved parameters and with appropriate oversight. Capabilities aligned with Visa’s Trusted Agent Protocol can help provide the identity, transparency and controls needed to support these interactions.

As part of the collaboration, LoopXPay has been registered in Visa’s Agentic Directory, enabling participating businesses and merchants to identify verified AI agents within the ecosystem. Supporting the implementation of Visa’s Trusted Agent Protocol, the Agentic Directory helps provide greater transparency into agent-driven interactions and confidence that participating agents have met Visa’s requirements.

“AI-powered commerce experiences can help businesses simplify purchasing and payments while maintaining the controls and oversight they require,” said Darren Parslow, Global Head, Visa Commercial Solutions, Visa. “For SMBs, that means less complexity in managing day-to-day commercial activities and more time focused on growth. As businesses increasingly look to embed intelligence into purchasing and payment experiences, trust will become a critical enabler of adoption. Through our collaboration with Lianlian, we are helping advance the trusted foundations that businesses will need to participate in this next era of commerce with confidence.”

Building on this milestone, Visa and Lianlian are exploring how AI agents can support a broader range of commercial activities, including procurement, digital advertising optimisation and B2B platform payments, helping advance trusted commerce through greater efficiency, transparency and control.

Zhang Zhengyu, Founder, Chairman of the Board and CEO, Lianlian DigiTech, said, “AI is reshaping the entire commercial value chain, where a growing number of business activities will be autonomously executed by AI agents, with payments serving as the critical infrastructure connecting them to global commerce. Leveraging its experience in global cross-border payments, compliance, as well as payment network, LianLian is actively building AI-native financial infrastructure, delivering an integrated suite of capabilities for the Agent Economy, spanning identity verification, transaction authorisation, intelligent payment, and global fund settlement. Through this collaboration with Visa, we aim to combine Lianlian’s AI-native capabilities with Visa’s trusted global network and commercial payment expertise to help businesses transact more securely, intelligently and efficiently in an increasingly agent-driven commerce environment.”

About Visa

Visa (NYSE: V) is a world leader in digital payments, facilitating transactions between consumers, sellers, financial institutions and government entities across more than 200 countries and territories. Our mission is to connect the world through the most innovative, convenient, reliable and secure payments network, enabling individuals, businesses and economies to thrive. We believe that economies that include everyone everywhere, uplift everyone everywhere and see access as foundational to the future of money movement. Learn more at Visa.com.

About Lianlian

Lianlian DigiTech Co., Ltd. (“Lianlian DigiTech” or “Lianlian”) was founded in 2009 and listed on the Main Board of the Hong Kong Stock Exchange in 2024 (stock code: 2598.HK). As China’s leading global provider of digital and intelligent payment services, Lianlian adheres to its mission of “Connecting the world, empowering global commerce” and pursues an “AI-Native + Globalization” strategy. The Company is committed to building a trusted global intelligent financial infrastructure, enabling seamless connectivity between Chinese enterprises and global businesses.  As of now, Lianlian has established a global licensing portfolio comprising 68 payment licenses and related qualifications, and holds a VATP license issued by the Hong Kong SFC. It supports services in more than 200 countries and regions and enables transaction settlement in over 140 currencies, connecting over 180 global e-commerce platforms and serving a cumulative total of over 13.3 million customers. Learn more at www.lianlian.com.

View original content to download multimedia:https://www.prnewswire.com/apac/news-releases/visa-and-lianlian-advance-trusted-b2b-agentic-commerce-through-loopxpays-first-live-b2b-agentic-transaction-302833916.html

SOURCE Visa Worldwide Pte. Limited

Continue Reading

Trending